Connect with us

Technology

Automated Microscopy Market to Grow by USD 1.84 Billion from 2024-2028, Driven by Increasing Adoption of Automated Systems in Laboratories and AI’s Role in Market Transformation – Technavio

Published

on

NEW YORK, Oct. 1, 2024 /PRNewswire/ — Report with the AI impact on market trends – The Global Automated Microscopy Market size is estimated to grow by USD 1.84 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 10.87% during the forecast period. Growing adoption of automated systems in laboratories is driving market growth, with a trend towards advances in automated microscopy However, high cost of laboratory instruments poses a challenge.Key market players include Agilent Technologies Inc., Anton Paar GmbH, Bruker Corp., Carl Zeiss AG, Danaher Corp., Hitachi Ltd., HORIBA Ltd., JEOL Ltd., Nikon Corp., Olympus Corp., Oxford Instruments plc, PAMAS PARTIKELMESS UND ANALYSESYSTEME GMBH, Prior Scientific Instruments Ltd., PVA TePla AG, Semilab Semiconductor Physics Laboratory Co. Ltd., Shimadzu Corp., Thermo Fisher Scientific Inc., Tibidabo Scientific Industries Ltd., Verder International BV, and Zaber Technologies Inc..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View the snapshot of this report

Automated Microscopy Market Scope

Report Coverage

Details

Base year

2023

Historic period

2017 – 2021

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 10.87%

Market growth 2024-2028

USD 1843.1 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

9.53

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 46%

Key countries

US, China, Germany, Canada, and France

Key companies profiled

Agilent Technologies Inc., Anton Paar GmbH, Bruker Corp., Carl Zeiss AG, Danaher Corp., Hitachi Ltd., HORIBA Ltd., JEOL Ltd., Nikon Corp., Olympus Corp., Oxford Instruments plc, PAMAS PARTIKELMESS UND ANALYSESYSTEME GMBH, Prior Scientific Instruments Ltd., PVA TePla AG, Semilab Semiconductor Physics Laboratory Co. Ltd., Shimadzu Corp., Thermo Fisher Scientific Inc., Tibidabo Scientific Industries Ltd., Verder International BV, and Zaber Technologies Inc.

Market Driver

Automated microscopy has revolutionized life sciences research by enabling detailed and efficient interrogation of cellular processes. Advanced automation technology is integral to the development of high-throughput imaging tools, allowing for rapid acquisition of multiple images without human intervention. High-throughput microscopy (HTM) enables the acquisition of images from a large number of treatments overnight or over several days, facilitating large-scale, image-based screening for novel genes and functions. Advancements in automated microscopy have led to the development of high-throughput FLIM-FRET microscopy, which rapidly quantifies protein-protein interactions in cells. This technology allows for quick interrogation of multiple cellular processes or multi-well plate samples in a high-throughput manner, benefiting biological studies such as predictive chemogenomics. Imaging analysis procedures help quantitatively determine complex cellular processes, such as autophagy. For instance, Oxford Instruments plc’s 3D mapping software offers rapid manual and semi-automated features for better microscopy image visualization, saving time and reducing user bias and error. Horiba, Ltd.’s new EasyImage software for Raman microscopy performs simple event-driven microscopy approaches and can be used for various applications, including cancer research. Automated microscopy enables life sciences professionals to explore, research, and evaluate more than ever before. The market for automated microscopy is expected to grow due to advancements in technology, providing opportunities for increased productivity and discovery in research. 

The Automated Microscopy market is experiencing significant growth due to its application in various sectors like academic institutions, healthcare diagnostics, and the biotechnology industry. Government funding and advancements in AI and ML technology are driving the market’s growth. In healthcare diagnostics, automated microscopy is revolutionizing cancer diagnosis with its data analysis capabilities. Telepathology solutions and cloud-based services enable remote diagnostics, making it more accessible. Miniaturization and motorized stages enhance the system’s efficiency, while high-resolution images and 3D imaging offer improved accuracy. Drug discovery benefits from automated microscopy’s high-throughput screening capabilities. Digital imaging systems and AI-assisted classification streamline sample analysis. Data collection and storage with data security are essential considerations for this market. The market includes optical microscopes, digital imaging systems, motorized stages, and high-resolution images for medical diagnostics. AI and ML are integral to the market’s future service model. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

Laboratories are essential for pharmaceutical and biotech companies in creating new drugs, and advanced research instruments have significantly reduced errors during research activities. However, the high cost of these instruments has become a challenge for life sciences tool and service providers, as companies are closely monitoring R&D expenses. Automation in laboratories enhances quality and efficiency, allowing technologists to focus on complex tasks. However, the high cost of automation systems, ranging from USD500,000 to USD3 million, limits their adoption to only a few large hospitals and commercial labs. Conducting over two million tests annually necessitates significant investments in automation systems. Technological advancements will influence the cost of automated microscopes, with an average price of around USD10,000. These factors may hinder the growth of the life sciences tools and services market and, in turn, the global automated microscopy market during the forecast period.Automated microscopy is revolutionizing various industries, including drug discovery, medical diagnostics, and materials science research. Traditional optical microscopes have been upgraded with motorized stages, digital imaging systems, and high-resolution cameras for enhanced image acquisition. Automation enables high-throughput screening, 3D imaging, time-lapse studies, and remote monitoring for long-term experiments. Advanced software and artificial intelligence (AI) capabilities facilitate image analysis and data management solutions. Compatibility and interoperability with various imaging technologies, such as scanning probe microscopes, cryo-electron microscopy, and confocal, multiphoton, and super-resolution microscopy, expand applications. Automation benefits diagnostic laboratories, research institutions, healthcare sector, forensics, genomic research, and pathology. Non-destructive imaging and imaging speed are crucial factors for high-resolution sample analysis. The market faces challenges in ensuring machine learning capabilities, data collection, and ensuring compatibility and interoperability between various systems.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This automated microscopy market report extensively covers market segmentation by

Type 1.1 Optical microscopes1.2 Electron microscopes1.3 Scanning probe microscopes1.4 OthersEnd-user 2.1 Hospitals2.2 Research facilities2.3 Diagnostic centersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Optical microscopes- The Automated Microscopy Market is experiencing significant growth due to increasing demand for efficient and accurate analysis in industries such as pharmaceuticals and biotechnology. Automated microscopy systems offer advantages like faster image analysis, reduced human error, and improved productivity. Key players in this market include Olympus, Leica Microsystems, and Nikon. Collaborations and partnerships are driving innovation in this sector, enhancing the market’s growth trajectory.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Automated microscopy refers to the use of advanced technologies to automate the process of capturing and analyzing images using optical microscopes. This market encompasses various applications, including drug discovery, medical diagnostics, and life sciences research. Automated microscopy systems incorporate motorized stages, digital imaging systems, high-resolution cameras, and sensitive detectors to produce high-quality images. Technologies such as confocal microscopy, multiphoton microscopy, and super-resolution microscopy offer enhanced image resolution and sensitivity. Image analysis, data management solutions, machine learning capabilities, and remote diagnostics are integral components of automated microscopy systems. Cloud-based solutions, miniaturization, and pay-as-you-go services are emerging trends in the market. Classification and service models are also essential aspects of the automated microscopy market.

Market Research Overview

Automated microscopy refers to the use of advanced technologies and systems to automate the process of microscopic image acquisition and analysis. This market encompasses various types of microscopes, including optical microscopes, scanning probe microscopes, cryo-electron microscopy, and more. Automation in microscopy enhances the capabilities of drug discovery, medical diagnostics, high-throughput screening, and research in fields such as materials science, forensics, and life sciences. Key technologies include motorized stages, digital imaging systems, high-resolution cameras, sensitive detectors, confocal microscopy, multiphoton microscopy, super-resolution microscopy, and advanced software with machine learning capabilities. Automation enables long-term experiments, remote monitoring, and high-throughput analysis, making it an essential tool in research institutions, academic institutions, healthcare diagnostics, and the biotechnology industry. The healthcare sector benefits from automation in microscopy for applications like cancer diagnosis, remote diagnostics, and telepathology solutions. Automated microscopy also offers cloud-based solutions, miniaturization, and data management solutions for improved data collection, data analysis capabilities, and data security. The market is driven by government funding, the need for non-destructive imaging, and the increasing demand for imaging speed and accuracy.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

TypeOptical MicroscopesElectron MicroscopesScanning Probe MicroscopesOthersEnd-userHospitalsResearch FacilitiesDiagnostic CentersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/automated-microscopy-market-to-grow-by-usd-1-84-billion-from-2024-2028–driven-by-increasing-adoption-of-automated-systems-in-laboratories-and-ais-role-in-market-transformation—technavio-302264737.html

SOURCE Technavio

Continue Reading

Technology

Rocket Companies to Announce Third Quarter 2026 Results on October 29, 2026

Published

on

By

DETROIT, Oct. 22, 2026 /PRNewswire/ — Rocket Companies, Inc. (NYSE: RKT) (“Rocket Companies” or “the Company”), the Detroit-based homeownership platform, today announced that the Company will issue its third quarter 2026 earnings on October 29, 2026. Leadership will host a conference call to discuss results at 4:30 p.m. ET on that date. A press release detailing the Company’s results will be issued prior to the call.

A live webcast of the event will be available on the “Events & Presentations” section of the Company’s Investor Relations website at ir.rocketcompanies.com. A replay of the webcast will be available on the Investor Relations website following the event.

About Rocket Companies

Founded in 1985, Rocket Companies (NYSE: RKT) is a Detroit-based homeownership platform including mortgage, real estate and personal finance businesses: Rocket Mortgage, Redfin, Rocket Close, Rocket Money and Rocket Loans.

With insights from more than 160 million calls with clients each year, more than 30 petabytes of data and a mission to Help Everyone Home, Rocket Companies is well positioned to be the destination for AI-fueled homeownership.

For more information, please visit the Company’s Corporate website or Investor Relations website.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rocket-companies-to-announce-third-quarter-2026-results-on-october-29-2026-302917496.html

SOURCE Rocket Companies, Inc.

Continue Reading

Technology

Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister

Published

on

By

SACRAMENTO, Calif., Oct. 22, 2026 /PRNewswire/ — Lunai Bioworks Inc. (Nasdaq: LNAI) (the “Company”) announced that on October 21, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000. The Company reported a stockholders’ deficit of $(9,024,946) in its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, and does not meet the alternative market value of listed securities or net income standards. Because the Company is subject to a mandatory Hearings Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(B), Nasdaq staff determined to delist the Company’s securities. Trading in the Company’s common stock on Nasdaq is expected to be suspended at the opening of business on October 30, 2026.

The Company will not request a hearing. Rather than contest the staff determination, the Company’s Board of Directors approved on October 22, 2026 the voluntary withdrawal of the Company’s common stock from listing on Nasdaq under Rule 12d2-2(c) under the Securities Exchange Act of 1934, as amended. The Board took this action because of the staff determination and the Company’s financial condition, and concluded that the cost of continued listing and SEC reporting is not justified.

The Company notified Nasdaq of its intention on October 22, 2026. The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) on or about November 2, 2026, and expects the delisting to become effective on or about November 12, 2026. The Company then intends to file a Form 15 to suspend its SEC reporting obligations, to the extent it is eligible to do so. The Company’s SEC reporting obligations will continue unless and until they are terminated or suspended in accordance with the SEC’s rules.

The Company does not intend to arrange for quotation of its common stock on any over-the-counter market and cannot assure that any trading market for its common stock will exist after trading on Nasdaq is suspended.

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the expected suspension of trading, the expected timing of the Form 25 and Form 15 filings, and the expected timing of delisting and deregistration. Actual results may differ materially due to risks and uncertainties, including Nasdaq and SEC procedures and the Company’s financial condition. The Company undertakes no obligation to update these statements, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lunai-bioworks-announces-receipt-of-nasdaq-determination-and-intention-to-voluntarily-delist-and-deregister-302917510.html

SOURCE Lunai Bioworks Inc.

Continue Reading

Technology

Bulletin from Sivers Semiconductors AB’s Extraordinary General Meeting on 22 October 2026

Published

on

By

KISTA, Sweden, Oct. 22, 2026 /PRNewswire/ — The Extraordinary General Meeting in Sivers Semiconductors AB (the “Company”) was held on 22 October 2026 and in particular the following resolutions were resolved.

Election of auditor

The Extraordinary General Meeting resolved, in accordance with the Nomination Committee’s proposal, to terminate the assignment of the Company’s auditor Deloitte AB and to elect Ernst & Young AB as new auditor for the period until the close of the next Annual General Meeting.

Resolution on a long-term incentive program

The Extraordinary General Meeting resolved to introduce a long-term incentive program (the “P11”) for employees of the group in the United States, Scotland, Sweden, India and China.

P11 comprises a maximum of 7,280,000 stock options entitling to purchase of the same number of shares, corresponding to approximately 2.0 per cent of the shares and votes in the Company after dilution. The stock options are granted free of charge, are not subject to any performance conditions, and may not be transferred or pledged. Each vested stock option entitles the employee to acquire one ordinary share between the third and the sixth anniversary of the date of grant, at a price corresponding to 110 per cent of the volume-weighted average price of the Company’s share on Nasdaq Stockholm during the five trading days immediately preceding the date of grant.

Resolution to authorise the Board of Directors to resolve on directed issue of Series C shares

The Extraordinary General Meeting resolved to authorise the Board of Directors to, until the next Annual General Meeting, resolve on a new issue of no more than 7,280,000 Series C shares to be subscribed for by a bank or securities company at a subscription price corresponding to the quota value.

The purpose is to secure delivery of shares to participants under the Company’s outstanding incentive programs and payment of related social security charges. The Series C shares will be reclassified into ordinary shares before transfer to participants.

Resolution to authorise the Board of Directors to resolve on repurchase of Series C shares and transfer of ordinary shares to secure payment of social security charges

The Extraordinary General Meeting resolved to authorise the Board of Directors to, until the next Annual General Meeting, resolve on repurchases of all outstanding Series C shares, at a price corresponding to the quota value.

The Board of Directors was further authorised to, until the next Annual General Meeting, transfer own ordinary shares on Nasdaq Stockholm within the applicable price range, or outside Nasdaq Stockholm to a bank or securities company with deviation from the shareholders’ preferential rights at such market discount as the Board of Directors deems appropriate, to the extent required to secure payment of social security charges related to the Company’s outstanding incentive programs.

For more information, please contact:

Vickram Vathulya, CEO, Sivers Semiconductors AB (publ)

Email: ir@sivers-semiconductors.com

Tel: +46 (0)8 703 68 00

About Sivers Semiconductors

Sivers Semiconductors is a critical enabler of a greener data economy with energy efficient photonics & wireless solutions. Our differentiated high precision laser and RF beamformer technologies help our customers in key markets such as AI Datacenters, SATCOM, Defense and Telecom solve essential performance challenges while enabling a much greener footprint. For additional information, please visit us at: www.sivers-semiconductors.com. (SIVE.ST)

CONTACT:

Media Contact   
Tyler Weiland 
Shelton Group
+1-972-571-7834
tweiland@sheltongroup.com

Company Contact
Heine Thorsgaard
CFO 
ir@sivers-semiconductors.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sivers-semiconductors/r/bulletin-from-sivers-semiconductors-ab-s-extraordinary-general-meeting-on-22-october-2026,c4414255

View original content:https://www.prnewswire.com/news-releases/bulletin-from-sivers-semiconductors-abs-extraordinary-general-meeting-on-22-october-2026-302917519.html

SOURCE Sivers Semiconductors

Continue Reading

Trending